Stocks / NASDAQ / Ayala Pharmaceuticals Inc.

Ayala Pharmaceuticals Inc.

Our Opinion

Ayala Pharmaceuticals Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

I’m very excited about this trial given the early signs of activity previously observed in Phase 1b study and in ACC Patient Derived Xenograft animal models with AL101 in tumors that harbor Notch activated mutations,” said Dr. Renata Ferrarotto, M.D., Associate Professor, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center. Read the following article

Company Description

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company. The Company is focused on developing and commercializing small molecule therapeutics for patients suffering from rare cancers. The Company’s portfolio of product candidates includes, AL101 and AL102, which targets the aberrant activation of the Notch pathway with gamma secretase inhibitors.

Company Website: